SCHEMBL5244789

SCHEMBL5244789

O=C(NCC1CCCCC1)C1CCCN(S(=O)(=O)c2ccccc2Cl)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.58
EPHX2 P34913 2/20 0.55
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
POLB P06746 2/20 0.50
DPP4 P27487 1/20 0.50
FAAH O00519 1/20 0.50
ALDH1A1 P00352 1/20 0.50
ATM Q13315 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5246510 0.96 HSD11B1 (0.54) HSD11B1MEN1KMT2APOLBDPP4
SCHEMBL5248027 0.85 LMNA (0.62) MEN1KMT2ADPP4ALDH1A1LMNA
SCHEMBL5247343 0.85 HSD11B1 (0.70) HSD11B1EPHX2MEN1KMT2AMAPT
SCHEMBL4306300 0.85 HSD11B1 (0.69) HSD11B1EPHX2MEN1KMT2AALDH1A1
SCHEMBL5243246 0.85 CYP19A1 (0.59) HSD11B1EPHX2MEN1KMT2APOLB
SCHEMBL5242732 0.83 KMT2A (0.71) MEN1KMT2ADPP4TSHRLMNA
SCHEMBL5243803 0.83 ALDH1A1 (0.65) MEN1KMT2AALDH1A1TP53TSHR
SCHEMBL5244196 0.83 LMNA (0.67) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL4961267 0.83 HSD11B1 (0.80) HSD11B1EPHX2MEN1KMT2APOLB
SCHEMBL613481 0.83 HSD11B1 (0.80) HSD11B1EPHX2MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866285-A1 1-SULFONYL-PIPERDINE-3-CARBOXYLIC ACID AMIDE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE FOR THE TREATMENT OF TYPE II DIABETES MELLITUS F. Hoffmann-Roche AG (CH) 2007-12-19 EP claimed
WO-2006094633-A1 1- SULFONYL-PI PERDINE- 3 -CARBOXYL I C ACID AMIDE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE FOR THE TREATMENT OF TYPE II DIABETES MELLITUS F. HOFFMAN-LA ROCHE AG (CH) 2006-09-14 WO claimed
US-20060199816-A1 Aryl sulfonyl piperidines GILLESPIE PAUL 2006-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199816-A1 Aryl sulfonyl piperidines GPR119, SLC5A2, GLS2 HSD11B1 1661/4885EPHX2 3131/4885MEN1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.